Allergy/Asthma News

Dupilumab, a drug typically used to treat moderate-to-severe eczema, may assist in reducing the rate of severe exacerbation in those aged 12 years and older with uncontrolled asthma.

Sanofi and Regeneron’s drug Dupixent led to clearer skin in most patients in phase 3 trial involving 12- to 17-year-olds with moderate-to-severe atopic dermatitis, according to a press release from the company.

The skin of children with early-onset atopic dermatitis exhibits significantly different phenotypes when compared with the skin of adults with a long-standing history with the disease, according to research published in The Journal of Allergy and Clinical Immunology.

In patients with severe eosinophilic asthma, long-term treatment with Nucala safely reduced exacerbations and improved asthma control, according to findings presented at the American Thoracic Society International Conference.

Patients who have been hospitalized because of an asthma exacerbation and are given antibiotics do not experience better short-term outcomes than those who do not receive antibiotic treatment, according to findings presented at the American Thoracic Society International Conference.

GlaxoSmithKline announced that the FDA has approved Arnuity Ellipta, a once-daily inhaled corticosteroid, for treating asthma in children aged as young as 5 years, according to a company press release.

All children in one cohort who were labeled as penicillin allergic but tested negative for the allergy were able to tolerate a challenge, according to findings published in Pediatrics.

Based on findings from a single-arm, open-label clinical trial, the FDA has approved Truvada for use as an HIV-1 pre-exposure prophylaxis option for teenagers who weigh at least 35 kg, according to an update issued by the organization.

Children aged 0 to 4 years are at an increased risk of asthma exacerbations than other children, with an additional increased risk for exacerbations in the spring and fall seasons,  according to research presented at the Pediatric Academic Societies 2018 Meeting.

The possible shortage of EpiPen and EpiPen Jr reported by NBC News and other mainstream media was worrisome but served as a reminder to plan ahead for food allergy-related emergencies, experts told Healio Family Medicine.